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Porphyromonas gingivalis suppresses adaptive
immunity in periodontitis, atherosclerosis, and
Alzheimer’s disease
Ingar Olsen1*, Martin A. Taubman2,3 and Sim K. Singhrao4
1Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway; 2Department of
Immunology and Infectious Diseases, Forsyth Institute, Cambridge, MA, USA; 3Department of
Developmental Biology, Harvard School of Dental Medicine, Harvard Medical School, Boston, MA, USA;
4Dementia & Neurodegeneration Research Group, School of Dentistry, College of Clinical and Biomedical
Sciences, University of Central Lancashire, Preston, UK
Porphyromonas gingivalis, a keystone pathogen in chronic periodontitis, has been found to associate with
remote body organ inflammatory pathologies, including atherosclerosis and Alzheimer’s disease (AD).
Although P. gingivalis has a plethora of virulence factors, much of its pathogenicity is surprisingly related to
the overall immunosuppression of the host. This review focuses on P. gingivalis aiding suppression of the host’s
adaptive immune system involving manipulation of cellular immunological responses, specifically T cells and B
cells in periodontitis and related conditions. In periodontitis, this bacterium inhibits the synthesis of IL-2 and
increases humoral responses. This reduces the inflammatory responses related to T- and B-cell activation, and
subsequent IFN-g secretion by a subset of T cells. The T cells further suppress upregulation of programmed cell
death-1 (PD-1)-receptor on CDcells and its ligand PD-L1 on CD11b-subset of T cells. IL-2 downregulates
genes regulated by immune response and induces a cytokine pattern in which the Th17 lineage is favored,
thereby modulating the Th17/T-regulatory cell (Treg) imbalance. The suppression of IFN-g-stimulated release
of interferon-inducible protein-10 (IP-10) chemokine ligands [ITAC (CXCL11) and Mig (CXCL9)] by
P. gingivalis capsular serotypes triggers distinct T cell responses and contributes to local immune evasion by
release of its outer membrane vesicles. In atherosclerosis, P. gingivalis reduces Tregs, transforms growth factor
beta-1 (TGFb-1), and causes imbalance in the Th17 lineage of the Treg population. In AD, P. gingivalis may
affect the bloodbrain barrier permeability and inhibit local IFN-g response by preventing entry of immune
cells into the brain. The scarcity of adaptive immune cells in AD neuropathology implies P. gingivalis infection
of the brain likely causing impaired clearance of insoluble amyloid and inducing immunosuppression. By the
effective manipulation of the armory of adaptive immune suppression through a plethora of virulence factors,
P. gingivalis may act as a keystone organism in periodontitis and in related systemic diseases and other remote
body inflammatory pathologies.
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T
here are 3,000 years of history suggesting the oral
influence, particularly of periodontitis on the gen-
eral health of human subjects (1). In periodontitis,
Porphyromonas gingivalis represents a keystone pathogen
causing microbial and immune dysbiosis (2). Although P.
gingivalis has a number of potent virulence factors (3),
much of its pathogenicity is due to its ability to subvert the
host’s immune defenses (4). Previously, we reviewed how P.
gingivalis can affect innate immunity in periodontitis, in
cardiovascular disease, and in Alzheimer’s disease (AD) by
modulating the inflammasome (5, 6) and neutrophil
functions (7). We have also discussed whether P. gingivalis
and other oral microorganisms have a role in the develop-
ment of AD (5, 8). The aim here is to review how P.
gingivalis may affect adaptive immunity in periodontitis
(Fig. 1) and related systemic diseases where atherosclerosis
is the primary initiator of vascular pathology (Fig. 2) and
subsequently AD (Fig. 3). It has to be said that the
adaptive and innate immune systems co-exist and provide
co-stimulatory signals necessary for the adaptive immune
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system and vice versa. The adaptive immune arm of
protection occurs in health, but during disease (period-
ontal and related systemic diseases) the beneficial effects
appear to be reduced. As an example, CD4T-lymphocytes
are an essential component in responses to microorgan-
isms during infectious diseases as they orchestrate the
functional activities of both the innate and adaptive
immune system (9). It will therefore not be possible to
completely distinguish, in this review, between responses
from the two different immune systems although the focus
will be on P. gingivalis suppression of adaptive immunity in
three inflammatory pathologies.
P. gingivalis
As mentioned earlier, P. gingivalis is described as a
keystone pathogen in periodontitis meaning that follow-
ing its initial colonization in the host, this bacterium can
influence specific populations of bacterial species that
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Fig. 1. P. gingivalis and its presumed contribution to periodontitis via adaptive immune suppression. Following P. gingivalis
infection, the outer membrane vesicles (OMVs) from P. gingivalis transfer LPS and gingipains to a lipid-binding site on an
antigen presenting cell (AP cell). Gingipains erode cells cleaving CD14 and the immune cell receptor (RANKL [receptor activator
of NF-kB ligand]) a TNF-related cytokine which binds to RANK, a protein expressed on the osteoclast progenitor cell activating
an intracellular signaling cascade via NF-kB resulting in suppression of IL-2 secretion. Intact CD14 on membrane and soluble
TLR4-MD2 (myeloid MD2 differentiation protein 2) can still function to promote the binding of LPS to the TLR4-MD2
complex and enlist intracellular cell signaling via NF-kB. The appropriate cytokine release or its suppression has implications on
cellular/adaptive immune responses which involve host defective IgG.
Adaptive immune responses through activated CD14 T cells and secretion of immunoglobulins (Ig) by B cells constrain the
subgingival biofilm or may give rise to disease progression. T cells can have both protective and destructive roles. Inhibition of IL-
2: P. gingivalis can modify adaptive immune response through interaction with dendritic cells inducing a cytokine pattern favoring
T-helper 17 (Th17) lineage and inhibiting the expression and accumulation of IL-2 which attenuates T cell proliferation and
communication. Arg-gingipain (Agp) protease is involved in suppression of IL-2 which contributes to self-propagation of P.
gingivalis in vivo. Th17/Treg imbalance: P. gingivalis can modify adaptive immune response by interaction with dendritic or
antigen presenting cells (APC cells) which induce a cytokine pattern favoring the Th17 cell population. The imbalance is also
promoted by P. gingivalis proteases because IL-1b is the most Th17 supporting cytokine and is the cytokine most resistant to P.
gingivalis protease cleavage modification of Th17/Treg balance which occurs by Th17 cell response inhibition and increasing Treg-
cell activation. IFN-g suppresses upregulation of programmed cell death: Secretion of IFN-g upregulation of programmed cell
death  1 (PD-1)  receptor on CD cells and its ligand PD-L1 on CD11b-T cells. Since the PD-L1/PD-1 signaling pathway
inhibits the T-cell response, the changes induced by P. gingivalis on the expression of these molecules could be a mechanism by
which P. gingivalis suppresses T-cell immunity. RANK-RANKL, OPG: Activated lymphocytes expressing surface receptor
activator of NF-kB ligand (RANKL) can bind to surface RANK expressed on hematopoietic progenitors of osteoclasts
(osteoclast progenitors) activating a signal transduction cascade leading to osteoclastogenesis (in the presence of macrophage
colonystimulating factor, MCSF). This gives rise to activation and differentiation of functional osteoclasts and periodontal
bone resorption. Osteoprotegerin (OPG), an inhibitor of RANKLRANK interaction, produced by gingival fibroblasts,
osteoblasts, and periodontal ligament fibroblasts, abrogates immune cell RANKL-dependent and destructive osteoclastic
periodontal bone resorption. OPG can enhance bone formation.
Symbols:  suppression,  upregulated,  leads to,  contribution from, toll-like receptor 4 (TLR 4) and  from the
osteoclast cell-surface receptor (RANK) and its membrane-bound ligand, mRANKL or sRANKL (Receptor activator of
nuclear factor-kB ligand),  P. gingivalis,  antibodies to P. gingivalis,  outer membrane vesicles (OMVs),  release
of cytokines,  osteoprotegerin (OPG),  cell-surface receptor CD14, RANK, a receptor expressed on the cell surface
of osteoclast progenitor cells.
Ingar Olsen et al.
2
(page number not for citation purpose)
Citation: Journal of Oral Microbiology 2016, 8: 33029 - http://dx.doi.org/10.3402/jom.v8.33029
reside in the same niche (2). Although inflammation
is a hallmark feature of gingivitis or periodontitis,
P. gingivalis is not a potent inducer of inflammation,
but rather a master of immune subversion and evasion
(10, 11). As an exemplar, P. gingivalis has a number of
enzymes and surface membrane and capsular proteins to
suppress the expression of neutrophil-recruiting chemo-
kines (family of small cytokines, or signaling proteins
secreted by cells), by eroding cells, cleaving CD14 and the
immune cell receptor (receptor activator of NF-kb ligand
 RANKL), or inducing subversive cross-talk signaling
between toll-like receptor (TLR-2) and other innate
immune receptors like the C5aR anaphylatoxin receptor
[reviewed in Refs. 2, 7]. Besides its atypical lipopolysac-
charide (LPS) structure side groups (4-acyl monopho-
sphates on lipid A), P. gingivalis LPS side groups can be
poor agonists or strong antagonists of TLR4 (10, 12). The
ability of P. gingivalis to manipulate the host response
and promote its chronic persistence in the periodontium
also benefits from the presence of companion species and
vice versa in subgingival plaque (4). The microbial and
immune dysbiosis, which it creates, occurs despite the fact
that P. gingivalis is often only present in low numbers
in diseased sites. Although the subversive effects of P.
gingivalis mostly have been related to innate immunity
(2, 7, 13), which is the host’s first defense met by
microbial pathogens, it also has several ways to subvert
the adaptive immune response within the periodontium
(Table 1). Arteries and the demented brain also suffer the
effects of P. gingivalis oral infection, albeit subtly, in the
brain compared with atherosclerosis.
T cells
T cells constitute one arm of the adaptive immune system
that is responsible for mounting a specific reaction
against foreign antigens. They provide the impetus and
signals for directing the cellular and antibody responses
necessary to clear foreign pathogens and antigens.
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Fig. 2. P. gingivalis and its presumed contribution to atherosclerosis via adaptive immune suppression. The schematic shows an
open blood vessel (black lines) with atherosclerotic plaque. Both the blood vessel and the atherosclerotic plaque contain classical
immune cells (naı¨ve and activated) with or without MHC class molecules and immunoglobulins (Y) in peripheral blood, and
foam cells restricted to the atherosclerotic plaque. Cytokines in health are in balance for all immune cells. M, monocyte (naı¨ve),
MF, macrophage (activated), T cell (naı¨ve), T cell (a) activated, DC (a) dendritic cells, B cell (a) activated, Y functional
antibodies (pink border with black), non-functional antibodies (black). Increase in the serum P. gingivalis IgG confirms the
involvement of adaptive/humoral immune responses of the host.
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CD4 lymphocytes have been divided into distinct
functional lineages called T-helper type 1 (Th1), Th2,
Th17, and T-regulatory (Treg) cells (9). T cells as well
as B cells are found in inflamed periodontal tissues (14, 15),
but little is known about the role of the individual T-cell
subsets in this oral condition. Studies on humans have
concluded that Th1- and Th17-derived cytokines are
released during the destructive periodontitis phase (active
disease) and Th2- derived cytokines are released during the
remission stage of periodontitis (1620). Adaptive immune
responses through activated CD4T cells and secretion of
immunoglobulins (Igs) by B cells constrain the subgingival
biofilm but may drive disease progression (21, 22). T cells
can therefore have both protective and destructive roles in
the human host.
P. gingivalis can suppress adaptive immunity in avariety
of ways (see Table 1). In general, this may be protective
against periodontal disease bone loss. However, in some
cases, P. gingivalis or its antigens (and also other micro-
organisms) can directly stimulate a destructive response
due to the presence of abundant T and B lymphocytes
in diseased periodontal gingival tissues (15). Activated
lymphocytes express surface receptor activator of the
RANKL and can bind to surface RANK expressed on
hematopoietic progenitors of osteoclasts (osteoclast pre-
cursors). The binding of RANK to osteoclast progenitors
activates a signal transduction cascade to initiate osteo-
clastogenesis in the presence of macrophage colony
stimulating factor (MCSF), thus giving rise to activation
and differentiation of functional osteoclasts and subse-
quent periodontal bone resorption (Fig. 1). For clarifica-
tion, RANKL and RANK are separate proteins in a
signaling pathway, and increased osteoclast development
causes an imbalance with the number of osteoblasts
resulting in increased bone resorption. Thus, it is clear
that the dysregulated progressive immune responses in the
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Fig. 3. P. gingivalis and its presumed contribution to AD via adaptive immune suppression. Vascular integrity with
atherosclerotic plaque formation compromises blood flow and the available oxygen. Th17/Treg imbalance leads to
immunosuppression. Insufficient cytokine levels (TGF-b and IFN-g) mean that neurons in the hippocampal dentate gyrus
cannot regenerate. During advancing age the blood-brain barrier (BBB) becomes leaky and if P. gingivalis infection persists,
BBB becomes even more permeable. The greater opening of the BBB allows entry of larger plasma proteins into the brain.
During aging, the brain shows largely Ab1-40 deposition and few neurofibrillary tangles (NFTs). In early (prodromal/EOAD)
and late-onset (LOAD) AD, copious amounts of Ab1-40/1-42 deposits and NFTs occur. It is hypothesized that in prodromal/
EOAD, Ab deposits associate with few migrated monocytes and Tregs and functional antibodies. These are able to form
antigen-antibody complexes (Ag-Ab complex) to clear Ab deposits. In LOAD, an antibody switch takes place (IFN-g
imbalance), during which non-functional antibody is secreted, which binds Ab, but does not promote its clearance by activated
microglia from the brain. More NFTs also accumulate.
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periodontal inflammatory infiltrate can lead to robustly
increased osteoclast frequency and activity (osteoclasto-
genesis) associated with active bone destruction. RANKL
melds bone resorptive events with activated immune
cell-mediated RANKL expression (23, 24). It is the key
intermediary linking immune cells to pathogenic bone loss
in both rheumatoid arthritis (25) and periodontal disease
(26, 27). Activated T cells and B cells have been linked
to the pathway of immune cell involvement in pathogenic
periodontal bone resorption by adoptive transfer of
RANKL-expressing antigen-specific Tor B cells in animal
models of experimental periodontitis (26, 2830) and also
in human disease (15, 27, 3032). As mentioned earlier,
B and T-lymphocytes are the primary cellular sources
of RANKL expression in the bone resorptive lesions of
periodontal disease. Whereas, in disease, the majority of
these cells express RANKL, few, if any, immune cells
from healthy tissue express RANKL (15). Therefore,
RANKL expressed by inflammatory immune cells are
key molecules that regulate osteoclast recruitment and
function (24, 33).This indicates that RANKL is a requisite
factor for the initiation of osteoclastogenesis in pathogenic
bone resorption lesions. Thus, bone destruction can be
caused by an inflammatory activation of the immune
system in rheumatoid arthritis and in periodontitis (34).
However, several immunological interventions related to
P. gingivalis suppression of adaptive immunity, for exam-
ple, inhibition of IL-2 or inducing a cytokine pattern
favoring the Th17 lineage impairment of inflammatory
responses and T cell activation (see Table 1) can alleviate
RANKL-induced bone resorption and render destructive
and/or protective effects.
Tregs are regulatory cells that provide immunological
tolerance to the individual and actively restrain the
immune system from distinguishing self from non-self
(35). Tregs control and suppress the activities of specific
effector T cells (Teffs) and myeloid lineage cells such as
dendritic cells, macrophages, and microglia that contri-
bute to innate immunity (35).
It is the balance between Th17 and Treg cells that
controls inflammation and depends overall on the activa-
tion of several transcription factors which regulate the
immune response through the secretion of pro- or anti-
inflammatory cytokines. Forkhead box P3 (Foxp3) is
a transcription factor that is necessary for the develop-
ment and differentiation of T cells into Tregs. In T cell
recognition and activation, CD4 and CD8 positive T cell
surface molecules are important because they bind to their
respective class I and class II major histocompatibility
complex ligands on an antigen presenting cell.
Inhibition of IL-2
P. gingivalis can influence responses of T cell lineages to
evade or suppress their adaptive responses (18, 36, 37).
This is achieved by inhibiting the expression and accumu-
lation of IL-2 (38), which attenuates T cell proliferation
and communication (39). P. gingivalis secretes proteinases
such as arg-gingipain (Rgp). Rgp protease is involved
in the suppression of IL-2 accumulation which contri-
butes toward the establishment and self-propagation
of P. gingivalis in vivo. IL-2 accumulation is affected by
P. gingivalis at the protein level and partially through
suppression of activator protein 1 (AP-1) (38). AP-1
is a transcription factor, which in this context, regulates
IL-2 gene expression following stimuli from P. gingivalis
infection.
Impairment of inflammatory responses and T-cell
activation
T cells produce IL-10 which is a critical cytokine
characterized by its anti-inflammatory properties. It is
involved in the regulation of the host’s immune responses
(40) and plays a role in impeding resolution of infection
(41). It is an important cytokine produced during infec-
tion with P. gingivalis (4244). Kobayashi et al. (45)
reported from studies on mice infected with P. gingivalis
that gingival Tregs were essential players in the down-
regulation of inflammatory responses through their IL-10
production and others suggest that the anti-inflammatory
Table 1. Methods by which P. gingivalis suppresses adaptive
immune responses
Method References
Periodontitis
Inhibition of IL-2 (38, 39)
Impairment of inflammatory responses and
T-cell activation
(4046)
Inhibition of IFN-g production by T cells (11, 37)
Upregulation of PD-1 and its ligand PD-L1 (37)
Downregulation of immune response
regulated genes
(47)
Inducing a cytokine pattern favoring the Th17
lineage
(36)
Modulation of the Th17/Treg imbalance (48, 49)
Suppression of IFN-g stimulated release of
IP-10, ITAC, and Mig
(5053)
Capsular serotypes trigger different
T-lymphocyte responses
(9, 54)
OMVs contribute to local immune evasion (55)
Atherosclerosis
Reduction of Tregs and TGD-b1 (65)
Th17/Treg imbalance (64, 68)
Targeting IL-2 production (38)
Alzheimer’s disease
Immune deficiency may impair clearance of
Ab from the brain
(8, 73, 74)
Inhibition of IFN-g response by T cells (77, 78)
Immunosuppressive effect caused by Tregs (71, 73, 79, 80)
Immune modulation caused by endotoxin (83, 84)
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effect of this cytokine may prevent bacterial clearance
(37). Kitamura et al. (46) also found that P. gingivalis
impairs T cell activation by cleaving CD4 and CD8
proteins on human T cells. The strategy of impeding
T cell function can be used by P. gingivalis to evade the
host immune system promoting the establishment and
proliferation of this bacterium in the host.
Inhibition of IFN-g production by T cells
Gaddis et al. (37) showed in mice that IL-10 generated
during the initial systemic exposure of host cells to
P. gingivalis caused inhibition of the IFN-g response by
T cells. However, neutralization of IL-10 in naı¨ve spleno-
cytes and CD4 and CD8 T cells was more effective
in increasing an IFN-g response in cells that were primed
with P. gingivalis. It therefore appears that IFN-g increases
macrophage-mediated opsonophagocytosis of P. gingivalis
and other bacteria. Suppression of IFN-g via IL-10
secretion could be another mechanism by which P.
gingivalis protects itself and its co-habiting species and
contributes to the chronicity of periodontal infection (11).
Gaddis et al. (37) also found in mice with intact TLR1
and TLR2 signaling that P. gingivalis induces the synthesis
of high levels of IL-10 by CD11b- T cells and CD4 and
CD8 T cells. The downstream effect of IL-10 appears to
inhibit IFN-g production by CD4 and CD8 T cells. In
this study, the fimA fimbriae of P. gingivalis were to a large
extent responsible for the induction of this subversive
TLR2/TLR1 signaling affecting IL-10 production (37).
This offers another mechanistic basis for how P. gingivalis
can subvert T cell function.
Upregulation of PD-1 and its ligand PD-L1
Gaddis et al. (37) reported that P. gingivalis infection
mediated upregulation of programmed death 1 (PD-1)-
receptor on CD cells and its ligand programmed death
ligand 1 (PD-L1) on CD11b-T cells. These effects appear
to depend partially on IL-10 as they remained independent
of TLR1/TLR2 signaling and/or the presence of fimA
fimbriae. Since the PD-L1/PD-1 signaling pathway inhibits
the T cell response, the changes induced by P. gingivalis on
the expression of these molecules could be another mech-
anism by which P. gingivalis suppresses T cell immunity.
Downregulation of immune responseregulated
genes
A proteomics microarray analysis in mice immunized with
P. gingivalis outer membrane antigens indicated that P.
gingivalis could undermine adaptive immunity by down-
regulating the expression of immune responseregulated
genes in splenic CD4 and CD8 T cells (47). A total of
1,141 and 1,175 genes, respectively, were downregulated,
while only 5 and 288 genes, respectively, were upregulated.
Sixty and 65 genes, respectively, were coded for immune
response proteins or proteins important for the pathogen-
esis of periodontal disease. Among the downregulated
genes were those encoding for cytokines, proteins involved
in Ig binding, antigen presentation, innate immunity,
extracellular matrix, and cell adhesion. It was clear from
this study that P. gingivalis suppresses the T cell response
in many ways including downregulating expression of
genes which affect the CD3 complex, CD2 binding protein
2, and CD8 expression.
Inducing a cytokine pattern favoring the Th17 lineage
P. gingivalis can also modify the adaptive immune response
through its interaction with dendritic cells that induce
a cytokine pattern favoring the Th17 lineage. In the
Moutsopoulos et al. (36) investigation, the Th17 cell
lineage was promoted by P. gingivalis proteases. This con-
clusion was reached because IL-1b released following P.
gingivalis infection of primed antigen presenting (dendri-
tic) cells appeared to be the most resistant cytokine in their
study. This implied that P. gingivalis drives production of
Th17-supporting cytokines (IL-1b, IL-6, IL-23) and not
Th1-related cytokines such as IL-12 (36). It would there-
fore appear that Th17/Treg cell responses play an impor-
tant role in the development of chronic periodontitis and
that their imbalance is involved in the pathogenesis of this
disease.
Modulation of the Th17/Treg imbalance via P.
gingivalis vaccination
The importance of the Th17/Treg imbalance in period-
ontitis was further supported by subcutaneous vaccination
with P. gingivalis in a murine model. The results demon-
strated that the vaccination inhibited the Th17 cell
response and increased the Treg cell response affording
protection to the mice from alveolar bone resorption and
inflammation (48). Similar results were obtained in the in
vivo experiment with all-trans retinoic acid (ATRA)
administration which modulated the Th17/Treg imbalance
and protected against experimental periodontitis (49).
The likely mechanism modulating the Th17/Treg imbal-
ance may therefore be inhibition of Th17 cell responses,
increased Treg cell activation, and reduced RANKL
expression on CD4 T cells (49).
In another murine model study performed by Wang
et al. (48), in which subcutaneous vaccination with P.
gingivalis ameliorated periodontitis by modulating the
Th17/Treg imbalance has been documented (48). They
reported that the expression levels of TGFb-1 and IL-10
mRNA were significantly increased (pB0.01) implying an
adverse role of these cytokines in modulating Th17/
Treg imbalance. Furthermore, in the spleen, the ratio
and number of Treg cells were significantly diminished
(pB0.05) supporting an immunosuppressive role of these
cytokines in their clonal expansion (48). Accordingly,
Th17 and Treg cells may be used to clarify the role of
adaptive immune responses in periodontal disease instead
of the originally proposed Th1/Th2 model (19).
Ingar Olsen et al.
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Suppression of IFN-g stimulated release of IP-10,
ITAC, and Mig
Jauregui et al. (50) found that P. gingivalis did not induce
the expression of the T cell chemokine interferon-
inducible protein 10 (IP-10) or (CXCL 10) from neutro-
phils, peripheral blood mononuclear cells, or gingival
epithelial cells. P. gingivalis also suppressed gamma
interferon-stimulated release of IP-10, ITAC (CXCL11),
and Mig (CXCL9) from epithelial cells. In addition, P.
gingivalis inhibited IL-10 secretion in a mixed infection
with the otherwise stimulatory Fusobacterium nucleatum.
IP-10, ITAC, and Mig are ligands for the CXCR3
inflammatory chemokine receptor and may have impor-
tant roles in T cell lymphopoiesis and the development of
innate immunity and inflammation (50). It was proposed
that suppression of IP-10 and other Th1-biasing chemo-
kines by P. gingivalis might destroy the balance of pro-
tective and destructive immunity in periodontal tissues,
thereby extending the target range of chemokine paralysis
(51). Another consequence of P. gingivalis suppression of
chemokine production might be the reduction of the
overall antimicrobial activity since many chemokines exert
antimicrobial activity similar to defensins in vitro (52, 53).
Capsular serotypes trigger different T-lymphocyte
responses
P. gingivalis occasionally synthesizes an extracellular
capsule and different serotypes have been defined based
on its capsular antigenicity. When dendritic cells were
primed with different P. gingivalis K-serotypes, distinct
T cell responses were elicited. While strains K1 (W83)
and K2 (HG 184) induced a Th1/Th17 pattern immune
response, K3 (A7A1-28), K4 (ATCC 49417), and K5 (HG
1690) induced a Th2 response. Accordingly, different
human T lymphocyte responses can be triggered by
different P. gingivalis capsular serotypes (9). This supports
results from a murine experimental model of periodontitis
where a divergence of the systemic immune response
following oral infection was observed with distinct strains
of P. gingivalis and where IL-10 was associated with
the least amount of alveolar bone loss (54). Therefore,
different strains of P. gingivalis vary in their ability to
induce T cell responses in vivo.
Outer membrane vesicles contribute to local immune
evasion
Local immune evasion of P. gingivalis was accomplished by
its outer membrane vesicles (OMVs) which promoted
monocyte unresponsiveness to live P. gingivalis (55).
Neutralization of IL-10 during OMV challenge partially
restored monocyte responsiveness to P. gingivalis while full
reactivity to this bacterium was regained by inhibiting the
target of rapamycin (mTOR) intracellular signaling path-
way which is the major signaling pathway for promot-
ing TLR2-/TLR4-mediated tolerance in monocytes. It
was speculated that continuous exposure to P. gingivalis
OMVs can induce selective tumor necrosis factor (TNF)
deficiency that makes microbial detection difficult and
thus represents a possible local immune evasion strategy of
P. gingivalis.
Atherosclerosis
A link between periodontitis and cardiovascular disease
has been proposed (56, 57) and in 2012 the American
Heart Association released a statement supporting an
association between periodontal disease and atherosclero-
tic vascular disease (ASVD) that is independent of known
confounders (58). Like periodontitis, atherosclerosis is a
complex condition with a suspected microbial etiology in
which P. gingivalis is attracting increasing attention for
its possible role in accelerating disease progression
(59, 60). Unsurprisingly, therefore, pathogenesis of ather-
osclerosis is associated with both innate and adaptive
immune responses. Maekawa et al. (61) claimed that oral
infection with P. gingivalis accelerates atheroma forma-
tion by shifting the lipid profile of the host. High titers
of antibodies to P. gingivalis have been detected in
patients with cardiovascular disease and stroke (62). P.
gingivalis invades cardiovascular cells and tissues [re-
viewed by Olsen and Progulske-Fox (63)] and probably
contributes to the progression of atherosclerosis (48, 61,
64) as depicted in Fig. 2.
Reduction of Tregs and TGF-b1
It is reported that in patients manifesting atherosclerosis,
P. gingivalis infection reduced the number of Tregs com-
pared with a control cohort without atherosclerosis
(65). Also the concentration of TGF-b1 was diminished
in patients infected with P. gingivalis. TGF-b1 has an
important role in the development of Tregs. As an example,
gastric cancer cells can induce Treg development via
producing TGF-b1 through which cross-talk between
the tumor and immune cells might regulate anti-tumor
immune response (66). The Treg population was decreased
in patients with type II fimA of P. gingivalis compared with
those with other types of fimbriae. Therefore, P. gingivalis
infection may be associated with dysregulation of Tregs
in atherosclerosis with type II fimA as the predominant
genotype.
Th17/Treg imbalance
Atherosclerosis is a chronic inflammatory disease that is
regulated by T lymphocyte subsets. According to Cai
et al. (64), P. gingivalis infection increases Th17 responses
during development of periodontitis. As for periodontitis,
development of atherosclerosis was originally thought to
be affected by the Th1/Th2 balance (67). However, this
view has changed in light of recent literature reporting
that a Th17/Treg imbalance is present in patients suffer-
ing from acute coronary syndrome as well (68). Since the
Th17/Treg balance controls inflammation, it is plausible
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to suggest that the balance of these two T cell subsets may
be important in both plaque destabilization and onset of
this syndrome. Tregs generate large amounts of TGF-b
isoforms and IL-10 and these proteins have an important
role in the pathogenesis of atherosclerosis by repressing
immune cell function. Cai et al. (64) found that Th17 cells
and Th17-related molecules are increased in the spleen
and the heart compared with Th1 cells and Treg cells
during atherosclerosis induced by P. gingivalis in ApoE-/-
mice. This suggested a potential role of proinflammatory
Th17 cell responses in the formation and progression of
atherosclerosis.
P. gingivalis targets IL-2 production
As mentioned earlier, Khalaf and Bengstsson (38) reported
that viable P. gingivalis cells targeted IL-2 expression
at the protein level. Reactive oxygen species production
and Ca2 were increased in response to P. gingivalis while
the activity of transcription factors AP-1 and NF-kB
fell below basal levels. T cells were not able to maintain a
stable IL-2 accumulation. Rgp proteinases were probably
involved in suppression of IL-2 accumulation since IL-2
was partly restored by leupeptin, but not by cathepsin
inhibitor as described elsewhere (38). Accumulation of IL-
2 is also affected by P. gingivalis at the protein level and
partially through suppression of AP-1 protein (38). It was
suggested that the change in IL-2 levels and thereby
alteration of the adaptive immune response might con-
tribute to progression of the inflammatory state in athero-
sclerosis due to the role of IL-2 in the clonal expansion of
regulatory T cells.
Alzheimer’s disease
Periodontitis is implicated as a plausible risk factor
for cognitive deficit via cardiovascular disease because of
the systemic inflammatory burden from infections. Our
unpublished data from ApoE-/- mice infected with P.
gingivalis mono-infections suggest that increased carbonyl
proteinrelated oxidative stress is present in their cerebral
microvasculature following induction of experimental
periodontitis and post atherosclerotic lesion appearance.
Deteriorating vascular pathology could be a plausible
factor in reducing the supply of sufficient oxygen to
the brain (Fig. 3). In addition, our unpublished findings
from in vitro studies indicate that Rgp proteases that are
intrinsically associated with the outer surface membrane
vesicles of P. gingivalis are capable of eroding cellular
communication between cells. For example, shedding
of surface membrane-bound CD14 receptor from neuro-
blastoma cell lines and loss of tight junction proteins
of endothelial cells as observed from our studies in ApoE-/-
P. gingivalis infected mice brains. These factors may render
the bloodbrain barrier (BBB) permeable to endotoxins
and expose the brain cells to intrinsic and extrinsic
inflammatory mediators. The central nervous system
(CNS) is free from lymphatic vessels and dendritic cells
and hence in AD, it is largely the innate immune system
that is considered to be involved in the neuropathology. In
AD, naı¨ve T cell infiltration is not widely recognized
whereas microglial cell and astroglial cell activation and
their antigen presenting cell functions are accepted.
It is fast becoming apparent that the strict regulation of
CNS immune privilege is disturbed during aging (69), and
this impairment allows micro bleeds to occur and the entry
of neurotoxic serum proteins into the hippocampus
becomes an inevitable consequence. The hippocampus is
an area related to learning and storage and retrieval
of memory and its failure leads to functional loss and
clinical symptoms of dementia with abnormal aggregated
hallmark protein amyloid beta (Ab) plaques and phos-
phorylated tau-coated neurofibrillary tangle formation.
Although the innate immune system has widely been
implicated in the inflammatory aspects of AD, the role of
the adaptive immune arm has only been considered since
the genome-wide association studies highlighted that
the inability for microglia to clear Ab from the brain may
relate to several immune system genes (70).
Immune reactions that affect neurodegeneration may
occur from within or outside the CNS although little
is known about the influence of peripheral immune
cell populations in AD brains either way. Migration of
antigen-specific CD4 T cells from the periphery to the
CNS with consequent immune cell interactions with
resident glial cells can affect neuroinflammation and
neuronal survival (35). The relative numerical and func-
tional dominance of the effector or regulatory T cells
are believed to determine the destructive or protective
mechanisms of these interactions.
Immune deficiency may impair clearance of Ab from
the brain
Recently, profound effects of peripherally derived neu-
trophils and Tregs were demonstrated in AD pathogenesis
(71, 72). To test the hypothesis that adaptive immunity
affects AD pathogenesis, an immune-deficient transgenic
AD mouse model (Rag-5xfAD) that lacked T cells, B cells,
and natural killer (NK) cells, that is, an adaptive immune
response, was found to restrain the pathogenesis of AD
by modulating microglial function (73). These mice
exhibited a greater than twofold increase in Ab. Therefore,
adaptive immune cell populations seem to have an
important role in restraining AD pathology (summarized
in Fig. 3). Gene expression analysis of the brain indicated
altered innate and adaptive immune pathways such as
changes in cytokine/chemokine signaling and decreased
Ig-mediated processes.
Neuroinflammation was also strongly exacerbated in
the Rag-5xfAD mice as seen through a shift in microglial
phenotype, increased cytokine production, and reduced pha-
gocytic capacity (73). In contrast to this, immune-intact
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5xfAD mice showed elevated levels of non-amyloid
reactive IgGs in association with microglia, and treatment
of Rag-5xfAD mice or microglial cells with pre-immune
IgG-increased Ab clearance (Fig. 3). This supported the
notion that the increase in AD pathology was driven not
by altered Ab production, but rather via its impaired
clearance and strongly suggested that defective antibody-
mediated clearance mechanisms may be involved. There-
fore, immune deficiency in humans may impair clearance
of Ab from the brain.
Additionally, the loss of B cells, T cells and NK cells in
the Rag-5xfAD mouse model considerably aggravated
amyloid pathogenesis, but it also increased the inflamma-
tory phenotype of microglia while decreasing their pha-
gocytic activity (73). Peripherally derived non-amyloid
reactive IgG appeared to enter the brain via a route
lacking the BBB (possibly the choroid plexus) and thereby
increased microglial phagocytosis of Ab in immune-intact
mice. Adaptive immune cell populations were therefore
thought to play an important role in restraining AD
pathology. In contrast to this, depletion of B cells and
their activation by T cells caused loss of adaptive-innate
immunity cross-talk and accelerated progression of
the disease (Fig. 3). The observations also indicated
that alterations in peripheral immune functions, as
those occurring with age, comorbid diseases, and genetic
variation, could seriously affect development and pro-
gression of AD, as suggested by Olsen and Singhrao
(8, 74). Togo et al. (75) proposed that the phenotype
of T cells in the AD brain is activated but not fully
differentiated. Nevertheless, vaccination studies suggested
that T cells and B cells have a role in the pathogenesis of
this dementing disease (72).
Inhibition of IFN-g response by T cells
P. gingivalis endotoxin (LPS) has been detected in the
brain of AD patients (76). TLR2-mediated IL-10 pro-
duction, following the initial systemic exposure to P.
gingivalis, inhibits the IFN-g T cell response. We propose
that this may be a mechanism to evade the host’s immune
response in the brain pending further experimental
confirmation. IFN-g is reported to increase neurogenesis
in wild-type mice and in a mouse model of AD (77),
and its lack due to P. gingivalis infection will contribute
overall to greater neuronal loss as neurogenesis will be
halted. From studies on mice, it was also suggested that
IFN-g plays a role in neuronal protection and repair and
that this enhanced neurogenesis possibly represents the
normal function of the immune system in controlling
brain inflammation and repair (77, 78).
Tregs’ immunosuppressive effect may be harmful
Tregs normally act to suppress excessive immune re-
sponses and protect against autoimmune disease onset
(79, 80). Notably, from AD mouse models, it seems that
this immunosuppressive activity may be detrimental in
impairing the adaptive immune system from responding
to and restraining AD pathology (73). Thus, when
Tregs are depleted, Ab pathology is dramatically reduced.
This was found in 5xFAD mice where transient depletion
of Foxp3 Tregs or pharmacological prevention of their
activity was followed by Ab clearance, mitigation of
neuroinflammatory response, and reversal of cognitive
decline (71). On the contrary, compounds that promote
Treg differentiation and function increase AD pathology.
If the observations from adaptive immune-deficient mice
correlate with data from successful pharmacological
prevention of Treg activity in human AD, this would
identify a previously unknown but significant role for the
adaptive immune system in this disease process.
Baruch et al. (71) identified systemic Foxp3 Treg-
mediated immunosuppression as a negative player in
AD pathology acting at least in part by reducing the
choroid plexus IFN-g availability necessary for gateway
activity in orchestrating recruitment of leukocytes to the
CNS. When a reparative immune response is required
in the brain, the ability to mount this response is limited
by systemically derived Tregs. Also, pharmacological
approaches interfering with Foxp3 Treg cell activity
demonstrated the existence of this inverse relationship
(71). Furthermore, timely and transient depletion of Tregs
was associated with a neuroprotective effect in 5xFAD
transgenic mice.
Age and endotoxin tolerance cause immune
modulation
Age-related changes in the adaptive immune system
have been well documented such as altered cytokine
patterns and a decline in antigen presenting function
(81) and decreased function of macrophages, NK cells,
and lymphocytes (82). Sun et al. (83) found that endo-
toxin tolerance is a case of immune modulation and
reprogramming rather than a global downregulation
of cytokine expression and function. Their studies were
based on endotoxin tolerance induced by P. gingivalis and
Escherichia coli in young (2 months) and middle-aged
(12 months) mice following a single or repeated LPS
stimulation.
Impaired immune tolerance to P. gingivalis LPS was
found to promote neutrophil migration and decreased
apoptosis in a monocytic cell line (84). Such a delay in
neutrophil apoptosis might prolong the inflammatory
response with increased potential for vital neuronal cell
and tissue damage.
Concluding remarks
Like the innate immune system, P. gingivalis also affects
adaptive immunity in several ways as indicated here for
periodontitis and related systemic diseases like athero-
sclerosis and AD. Notably, P. gingivalis uses many of the
methods to evade adaptive immunity in periodontitis as it
P. gingivalis suppresses adaptive immunity
Citation: Journal of Oral Microbiology 2016, 8: 33029 - http://dx.doi.org/10.3402/jom.v8.33029 9
(page number not for citation purpose)
does in systemic diseases and possibly AD. Therefore,
it would not be surprising to suggest that P. gingivalis
may have co-evolved with the host’s immune defense
developing strategies to overcome protective host barriers
and to modulate the host’s defense systems to its own
advantage. This has been attributed to P. gingivalis being
able to endure inflammation and also being able to
exploit inflammation for its own sustenance and survival.
In addition, P. gingivalis can invade periodontal, athero-
sclerotic, and brain tissue, thereby avoiding immune
surveillance and maintaining its viability. By these efforts
and through a plethora of other virulence factors, it may
act as a keystone organism both in periodontitis and
related systemic diseases and other remote body inflam-
matory pathologies including dementia.
Periodontal pathogenic bacteria play a key role in
adaptive immune-mediated bone destruction by activated
immune cell RANKL expression osteoclastogenesis (see
section on T cells, Fig. 1 and Table 1). P. gingivalis can
suppress this adaptive immune response which can also
be protective [for review, see Ref. (85)]. Immunological
mechanisms to interfere with immune cell-mediated
bone resorption have also been reviewed (86). Thus, a
new concept of periodontal pathogenesis therapeutic
strategy utilizing suppressive adaptive immunity induced
by P. gingivalis may reduce some immune-mediated
periodontal disease bone resorption (82) and ameliorate
the disease (87).
Thus, induction of P. gingivalis suppression of adaptive
immunity can represent a unique type of immune therapy
to ameliorate immune cellmediated, RANKL-dependent
osteoclastogenesis and periodontal bone resorption (88).
This novel induction of immune therapy and direct
injection of anti-RANKL antibody (89) and other anti-
body to pathogenesis factors (90) point to the significance
of immune therapy as a potentially powerful therapeutic
antagonist of diseased periodontal bone resorption.
However, P. gingivalis is not alone in being responsible
for disease development neither in periodontal nor in
systemic diseases or dementia. Although it can modulate
the growth of other bacteria in the subgingival biofilm,
periodontitis and its related systemic diseases are not
the effect of a single bacterium. Each bacterium in a
cluster with quorum sensing-like properties may affect the
responses induced by others and vice versa. Unfortunately,
at present, we are far from understanding the complex
microbial-host interactions or the inter-microbial interac-
tions that promote either health or disease in vivo.
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